Financials
- Market Capitalization 1.85 B
- Employee 291
- Founded 2004
- CEO N/A
- Website www.urogen.com
- Headquarter Israel
- FIGI N/A
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-7.34
Rapporto prezzo/fatturato
11.93
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 1979 | XERS Xeris Biopharma Holdings, Inc. - Common Stock | 10.30 USD | -1.53% | +1.88% | +35.70% | +29.23% | 1.88 B USD | ||
| 1988 | VIR Vir Biotechnology, Inc. - Common Stock | 10.79 USD | -4.51% | -5.76% | +0.56% | +80.43% | 1.83 B USD | ||
| 2007 | MESO Mesoblast Limited - American Depositary Shares | 13.94 USD | -2.31% | +2.20% | -8.11% | -21.64% | 1.81 B USD | ||
| 2014 | XNCR Xencor, Inc. - Common Stock | 24.04 USD | -3.99% | -1.03% | -2.71% | +72.33% | 1.79 B USD |